相似文献
1
Development of enteric coated flurbiprofen tablets using Opadry/Acryl-Eze system--a technical note.
AAPS PharmSciTech. 2008;9(1):116-21. doi: 10.1208/s12249-007-9005-9. Epub 2008 Jan 18.
2
A Novel Approach to Flurbiprofen Pulsatile Colonic Release: Formulation and Pharmacokinetics of Double-Compression-Coated Mini-Tablets.
AAPS PharmSciTech. 2015 Dec;16(6):1465-73. doi: 10.1208/s12249-015-0340-y. Epub 2015 May 28.
3
Influence of operational variables on properties of piroxicam pellets prepared by extrusion-spheronization: a technical note.
AAPS PharmSciTech. 2007 Mar 9;8(1):20. doi: 10.1208/pt0801020.
4
Gastroretentive drug delivery system of carbamazepine: formulation optimization using simplex lattice design: a technical note.
AAPS PharmSciTech. 2007 Feb 9;8(1):11. doi: 10.1208/pt0801011.
5
Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
Drug Dev Ind Pharm. 2010 Feb;36(2):180-9. doi: 10.3109/03639040903468811.
6
Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: a technical note.
AAPS PharmSciTech. 2007 Feb 16;8(1):13. doi: 10.1208/pt0801013.
7
Evaluation of microcrystalline cellulose prepared from sisal fibers as a tablet excipient: a technical note.
AAPS PharmSciTech. 2007 Feb 2;8(1):8. doi: 10.1208/pt0801008.
8
Effect of Eudragit RS 30D and talc powder on verapamil hydrochloride release from beads coated with drug layered matrices.
AAPS PharmSciTech. 2008;9(1):75-83. doi: 10.1208/s12249-007-9008-6. Epub 2008 Jan 9.
9
Film-coated matrix mini-tablets for the extended release of a water-soluble drug.
Drug Dev Ind Pharm. 2015 Apr;41(4):623-30. doi: 10.3109/03639045.2014.891128. Epub 2014 Feb 24.
10
Preparation and assessment of novel coprocessed superdisintegrant consisting of crospovidone and sodium starch glycolate: a technical note.
AAPS PharmSciTech. 2007 Feb 2;8(1):9. doi: 10.1208/pt0801009.
引用本文的文献
1
Enhancing the Drug Release and Physicochemical Properties of Rivaroxaban via Cyclodextrin Complexation: A Comprehensive Analytical Approach.
Pharmaceuticals (Basel). 2025 May 22;18(6):761. doi: 10.3390/ph18060761.
2
Formation and Physico-Chemical Evaluation of Nifedipine-hydroxypropyl-β-cyclodextrin and Nifedipine-methyl-β-cyclodextrin: The Development of Orodispersible Tablets.
Pharmaceuticals (Basel). 2022 Aug 12;15(8):993. doi: 10.3390/ph15080993.
3
Enteric-coated insulin microparticles delivered by lipopeptides of iturin and surfactin.
Drug Deliv. 2018 Nov;25(1):23-34. doi: 10.1080/10717544.2017.1413443.
4
Bioactive protein fraction DLBS1033 containing lumbrokinase isolated from Lumbricus rubellus: ex vivo, in vivo, and pharmaceutic studies.
Drug Des Devel Ther. 2014 Sep 25;8:1585-93. doi: 10.2147/DDDT.S66007. eCollection 2014.
本文引用的文献
1
Stabilization and target delivery of Nattokinase using compression coating.
Drug Dev Ind Pharm. 2007 May;33(5):495-503. doi: 10.1080/03639040601050247.
2
Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Eur J Pharm Biopharm. 2007 Sep;67(2):464-75. doi: 10.1016/j.ejpb.2007.02.021. Epub 2007 Mar 7.
3
A novel approach in the assessment of polymeric film formation and film adhesion on different pharmaceutical solid substrates.
AAPS PharmSciTech. 2004 Apr 5;5(2):e29. doi: 10.1208/pt050229.
4
Diffusion of a freely water-soluble drug in aqueous enteric-coated pellets.
AAPS PharmSciTech. 2002;3(2):E16. doi: 10.1208/pt030216.
5
Influence of aqueous coatings on the stability of enteric coated pellets and tablets.
Eur J Pharm Biopharm. 1999 Jan;47(1):39-50. doi: 10.1016/s0939-6411(98)00086-1.
6
Aqueous ethylcellulose dispersion of ethylcellulose. I. Evaluation of coating process variables.
Pharm Res. 1993 Apr;10(4):525-34. doi: 10.1023/a:1018989717297.
Zotero 插件